{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:35:59Z","timestamp":1787009759284,"version":"build-2736575974"},"reference-count":33,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003524","name":"Ministry of Business, Innovation and Employment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007608","name":"AgResearch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["FASEB BioAdvances"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Therapeutic monoclonal antibodies (mAbs) represent one of the most important classes of pharmaceutical proteins to treat human diseases. Most are produced in cultured mammalian cells which is expensive, limiting their availability. Goats, striking a good balance between a relatively short generation time and copious milk yield, present an alternative platform for the cost\u2010effective, flexible, large\u2010scale production of therapeutic mAbs. Here, we focused on cetuximab, a mAb against epidermal growth factor receptor, that is commercially produced under the brand name Erbitux and approved for anti\u2010cancer treatments. We generated several transgenic goat lines that produce cetuximab in their milk. Two lines were selected for detailed characterization. Both showed stable genotypes and cetuximab production levels of up to 10\u00a0g\/L. The mAb could be readily purified and showed improved characteristics compared to Erbitux. The goat\u2010produced cetuximab (gCetuximab) lacked a highly immunogenic epitope that is part of Erbitux. Moreover, it showed enhanced binding to CD16 and increased antibody\u2010dependent cell\u2010dependent cytotoxicity compared to Erbitux. This indicates that these goats produce an improved cetuximab version with the potential for enhanced effectiveness and better safety profile compared to treatments with Erbitux. In addition, our study validates transgenic goats as an excellent platform for large\u2010scale production of therapeutic mAbs.<\/jats:p>","DOI":"10.1096\/fba.2020-00059","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T11:38:47Z","timestamp":1597491527000},"page":"638-652","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Transgenic goats producing an improved version of cetuximab in milk"],"prefix":"10.1096","volume":"2","author":[{"given":"G\u00f6tz","family":"Laible","sequence":"first","affiliation":[{"name":"AgResearch Ruakura Research Centre Hamilton New Zealand"},{"name":"School of Medical Sciences University of Auckland Auckland New Zealand"},{"name":"Maurice Wilkins Centre for Molecular Biodiscovery Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Cole","sequence":"additional","affiliation":[{"name":"AgResearch Ruakura Research Centre Hamilton New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid","family":"Brophy","sequence":"additional","affiliation":[{"name":"AgResearch Ruakura Research Centre Hamilton New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Maclean","sequence":"additional","affiliation":[{"name":"AgResearch Ruakura Research Centre Hamilton New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"How Chen","sequence":"additional","affiliation":[{"name":"LFB\u2010USA Framingham MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan P.","family":"Pollock","sequence":"additional","affiliation":[{"name":"LFB\u2010USA Framingham MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Cavacini","sequence":"additional","affiliation":[{"name":"MassBiologics of the University of Massachusetts Medical School Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Fournier","sequence":"additional","affiliation":[{"name":"LFB Biotechnologies Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"De Romeuf","sequence":"additional","affiliation":[{"name":"LFB Biotechnologies Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Masiello","sequence":"additional","affiliation":[{"name":"LFB\u2010USA Framingham MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Gavin","sequence":"additional","affiliation":[{"name":"LFB\u2010USA Framingham MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Wells","sequence":"additional","affiliation":[{"name":"AgResearch Ruakura Research Centre Hamilton New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry M.","family":"Meade","sequence":"additional","affiliation":[{"name":"LFB\u2010USA Framingham MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,30]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3040"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2009.10.008"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2009.05.008"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7799(03)00190-2"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2007.11.005"},{"key":"e_1_2_9_7_1","first-page":"50","article-title":"Transgenic technology: a validated approach for large\u2010scale manufacturing","author":"Echelard Y","year":"2009","journal-title":"Innovations in Pharmaceutical Technology"},{"key":"e_1_2_9_8_1","first-page":"619\u2013620, 626","article-title":"Pharmaceutical approval update","volume":"39","author":"Goldenberg MM","year":"2014","journal-title":"P T"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0409-302"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0806-877"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiotec.2012.09.005"},{"key":"e_1_2_9_12_1","unstructured":"US_FDA.FDA approves additional treatment for adults and adolescents with hemophilia A or B and inhibitors.2020."},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31417-2"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.06.003"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074943"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1912"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)80052-G"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt783"},{"key":"e_1_2_9_19_1","unstructured":"AndrewsS.FastQC: a quality control tool for high throughput sequence data.2010. Available online athttp:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc."},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu170"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2478"},{"key":"e_1_2_9_22_1","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA\u2010MEM","author":"Li H","year":"2013","journal-title":"arXiv:1303.3997"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1754"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/10495390009525943"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.12.1947"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202069200"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2016.03.002"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2012.16"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200111000-00014"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.003"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03992.x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000303"},{"key":"e_1_2_9_34_1","article-title":"Cetuximab produced from a goat mammary gland expression system is equally efficacious as innovator cetuximab in model systems of cancer","author":"Wang Q","year":"2020","journal-title":"bioRxiv"}],"container-title":["FASEB BioAdvances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1096%2Ffba.2020-00059","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fba.2020-00059","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fba.2020-00059","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fba.2020-00059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:52:16Z","timestamp":1761695536000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fba.2020-00059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,30]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1096\/fba.2020-00059"],"URL":"https:\/\/doi.org\/10.1096\/fba.2020-00059","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.05.137463","asserted-by":"object"}]},"ISSN":["2573-9832","2573-9832"],"issn-type":[{"value":"2573-9832","type":"print"},{"value":"2573-9832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,30]]},"assertion":[{"value":"2020-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}